Newsfeeds - Spark Newswire

4 minute read

53 Biggest Movers From Yesterday

Today, 8:58 AM

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum Co. for a digital solution to manage Marine Logistics.

ALVR

2 minute read

28 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 8:58 AM

Gainers Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) climbed 58.3% to $2.2950 after jumping around 22% on Tuesday.

ALVR

1 minute read

Lexaria Biosciences Shares Spike To Afternoon High On Volume Following Circulation Of Zack’s Small Cap Research Note On Stock Showing $15 Valuation Target

By Benzinga Newsdesk

Today, 8:58 AM

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_04192022_LEXX_Vandermosten.pdf

LEXX

3 minute read

FDA
News

Lexaria Commences Multi-Week Human Clinical Hypertension Study

By Benzinga Newsdesk

Today, 8:58 AM

Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that it has begun its multi-week human

LEXX

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 8:58 AM

Gainers

BFRI

2 minute read

Why Lexaria Shares Are Rising Today

By Vandana Singh

Today, 8:58 AM

Lexaria Bioscience Corp (NASDAQ:LEXX) said that all data analyses from its simulated pulmonary hypertension clinical study HYPER-H21-3 are complete, assessing…

LEXX

1 minute read

‘Global Cannabis Stock Index Barely Misses Breaking One Year Losing Streak in March’ -Alan Brochstein’s New Cannabis Ventures

By Benzinga Newsdesk

Today, 8:58 AM

https://www.newcannabisventures.com/global-cannabis-stock-index-barely-misses-breaking-one-year-losing-streak-in-march/

AGFY

2 minute read

Lexaria Bioscience Reports First Phase Of Its Epilepsy Research Program Begun This Week; DehydraTECH-CBD Test Articles Have Been Manufactured, Delivered To Third-Party Lab Engaged To Complete Research

By Benzinga Newsdesk

Today, 8:58 AM

Program EPIL-A21-1 will compare effectiveness of FDA-approved Epidiolex to DehydraTECHTM-CBD for reducing seizure activity; DehydraTECH-CBD test articles have been delivered to the laboratory ready to commence dosing.

LEXX

6 minute read

Penny Stocks

LEXX: 1Q:22 Results & Other Things that Came Up

By Zacks Small Cap Research

Today, 8:58 AM

By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT

LEXX

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 8:58 AM

Gainers ContraFect (NASDAQ:CFRX) stock moved upwards by 4.9% to $2.76 during Friday's after-market session. The company's market cap stands at $108.5 million.

ATOS